Loading...
 
Back to the list
Mediterr J Rheumatol 2016;27(2):34-5
Article Links
How to reduce costs of biological treatments in patients with Rheumatoid Arthritis: The Dutch experience
Piet L.C.M. van Riel
Authors Information
Department of Rheumatology Bernhoven, The Netherlands and Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
Abstract
This paper has no abstract.
Keywords: Rheumatoid Arthritis, DMARDs, csDMARDs, bDMARDs, biosimilars, tapering, biological treatment, remission